Cannagistics, Inc. (CNGT) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cannagistics, Inc. (CNGT) trades at $0.0001 with AI Score 44/100 (Grade C). Cannagistics, Inc. operates as a developer, marketer, and seller of OTC, pharmaceutical, nutraceutical, cosmetic, and health and wellness products. Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for CNGT: CNGT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CNGT against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CNGT: 1/3 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Cannagistics, Inc. (CNGT) Financial Services Profile
Cannagistics, Inc., operating within the financial services sector as a shell company, focuses on developing and marketing a diverse portfolio of OTC, pharmaceutical, and nutraceutical products. Its offerings span health and wellness categories, distributed through various channels, positioning it within the competitive landscape of consumer health products.
What Is the Investment Thesis for CNGT?
Cannagistics, Inc. presents a high-risk, high-reward investment profile given its OTC listing and limited financial information. The company's diverse product portfolio, ranging from nutraceuticals to agricultural products, offers potential revenue streams, but also introduces operational complexity. With a market capitalization of $0.00 billion and a negative P/E ratio, the company's financial performance requires careful scrutiny. The beta of 3.28 indicates high volatility compared to the market. Potential catalysts include successful product launches and expansion into new markets, but these are speculative. Investors should conduct thorough due diligence, focusing on the company's financial disclosures, revenue generation, and competitive positioning. The company's reliance on wholesale, retail, and e-commerce channels exposes it to market fluctuations and competitive pressures.
Based on FMP financials and quantitative analysis
CNGT Key Highlights
Market capitalization of $0.00 billion, indicating a micro-cap company with limited financial resources.
- Negative P/E ratio, reflecting the company's current lack of profitability.
- Beta of 3.28, suggesting high volatility compared to the overall market.
- No dividend yield, indicating that the company is not currently returning capital to shareholders.
- Operates with a single employee, highlighting the company's limited operational scale.
Who Are CNGT's Competitors?
CNGT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| NIHL New Infinity Holdings, Ltd. | $0.10 | +0.00% | $10.8M | 62 |
| LRGR Luminar Media Group, Inc. | $0.50 | +47.06% | $22.4M | 68 |
| CLAYU Chavant Capital Acquisition Corp. | $10.97 | +18.34% | $27.5M | 62 |
| CLAY Chavant Capital Acquisition Corp. | $10.66 | +6.39% | $29.6M | 62 |
| INACU Indigo Acquisition Corp. | $12.08 | +16.94% | $34.9M | 60 |
| HHGC HHG Capital Corporation | $11.12 | +0.09% | $56.2M | 63 |
| MAAQ Mana Capital Acquisition Corp. | $5.99 | -24.18% | $57.0M | 61 |
| RCLFU Rosecliff Acquisition Corp I | $11.33 | +11.74% | $77.2M | 62 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CNGT's Key Strengths?
Diverse product portfolio across multiple health and wellness categories.
- Distribution network encompassing wholesale, retail, and e-commerce channels.
- Proprietary formulations for select products.
- Established presence in niche market segments.
What Are CNGT's Weaknesses?
Limited financial resources and market capitalization.
- Dependence on a small number of employees.
- Lack of profitability and negative P/E ratio.
- High beta indicating significant volatility.
What Could Drive CNGT Stock Higher?
Expansion of product distribution through e-commerce platforms.
- Development and launch of new health and wellness products.
- Strategic partnerships with retail chains.
- Potential for increased brand awareness through marketing initiatives.
- Possible acquisitions or mergers to expand market share.
What Are the Key Risks for CNGT?
Limited financial resources and market capitalization.
- Dependence on a small number of employees.
- Intense competition from larger, more established companies.
- Evolving consumer preferences and market trends.
- Regulatory scrutiny and compliance requirements.
What Are the Growth Opportunities for CNGT?
- Growth opportunity 1: Expansion of e-commerce presence: Cannagistics can capitalize on the growing e-commerce market by enhancing its online sales channels. By investing in its online platform, improving its digital marketing strategies, and offering competitive pricing, Cannagistics can attract a wider customer base and increase its sales volume. This strategy requires investment in technology and logistics, but offers the potential for significant revenue growth.
- Growth opportunity 2: Strategic partnerships with retail chains: Cannagistics can pursue partnerships with major retail chains to increase its product distribution. Securing shelf space in established retail stores would provide access to a larger customer base and enhance brand visibility. This strategy requires negotiating favorable terms with retailers and ensuring consistent product supply. The timeline for establishing such partnerships could range from several months to a year, depending on the negotiation process and retailer requirements.
- Growth opportunity 3: Development of innovative products: Cannagistics can invest in research and development to create new and innovative products that address unmet consumer needs. Focusing on emerging trends in health and wellness, such as personalized nutrition and natural remedies, could provide a competitive edge. The timeline for developing and launching new products can vary depending on the complexity of the product and regulatory requirements, but typically ranges from one to three years.
- Growth opportunity 4: Geographic expansion into new markets: Cannagistics can expand its operations into new geographic markets, both domestically and internationally. Identifying regions with strong demand for its products and establishing distribution networks in those areas could drive revenue growth. This strategy requires careful market research and adaptation of products to local preferences. The timeline for geographic expansion can vary depending on the target market and regulatory requirements, but typically ranges from one to two years.
- Growth opportunity 5: Leveraging veterinary and agricultural products: Cannagistics can further develop and market its products for veterinary and agricultural use. The market for animal health and agricultural products is substantial, offering opportunities for diversification and revenue growth. By focusing on innovative solutions for animal care and crop enhancement, Cannagistics can tap into these growing markets. The timeline for developing and marketing these products can vary depending on regulatory requirements and market acceptance, but typically ranges from one to two years.
What Are CNGT's Competitive Advantages?
- Diverse product portfolio spanning multiple health and wellness categories.
- Proprietary formulations for certain products, such as Canagel.
- Distribution network encompassing wholesale, retail, and e-commerce channels.
- Established brand presence in select market segments.
What Does CNGT Do?
Cannagistics, Inc., formerly known as Precious Investments, Inc., underwent a name change in May 2019, marking a shift in its business focus. Incorporated in 2004 and based in Hauppauge, New York, the company develops, markets, and sells a range of over-the-counter (OTC), pharmaceutical, nutraceutical, cosmetic, and health and wellness products. Its product portfolio includes Canagel, an anhydrous hydrogel composition and delivery system; Silverpro, a compression fabric; KidzStrips, a thin film children's toothpaste strip; and ImmuniZin, an immune booster, as well as HydroSoil, a novel fertilizer. Cannagistics also offers IcyEase, an ice pack for muscle/joint pain; Slim-D, an appetite-suppressant oral strip; Energy Lighting Strips for oral energy; Micro Voltage Trans Derm C for pain; and CBD 600, a hemp rich oral tincture. These products target various consumer needs, including pain relief, anti-aging, hygiene, energy, and immune system and biochemical support, as well as skin creams for treatment of disorders and rejuvenations. The company also provides products for veterinary and agricultural use, expanding its reach beyond human consumers. Cannagistics distributes its products through a mix of wholesale and retail channels, including brick and mortar stores and e-commerce platforms, aiming to reach a broad customer base.
What Products and Services Does CNGT Offer?
- Develops over-the-counter (OTC) products.
- Markets pharmaceutical products.
- Sells nutraceutical products.
- Offers cosmetic products.
- Provides health and wellness products.
- Distributes products through wholesale channels.
- Sells products through retail establishments.
- Utilizes e-commerce platforms for sales.
How Does CNGT Make Money?
- Develops and manufactures a range of health and wellness products.
- Sells products through wholesale distribution to retailers.
- Markets products directly to consumers through e-commerce platforms.
- Generates revenue through product sales.
What Industry Does CNGT Operate In?
Cannagistics, Inc. operates within the shell companies industry, a segment of the financial services sector characterized by companies with limited operations and often speculative ventures. The market for OTC, pharmaceutical, nutraceutical, and cosmetic products is highly competitive, with established players and evolving consumer preferences. Cannagistics' success depends on its ability to differentiate its products, establish effective distribution channels, and manage its operations efficiently. The company faces competition from larger, more established companies with greater resources and brand recognition. The industry is also subject to regulatory scrutiny and evolving consumer trends, requiring companies to adapt and innovate to maintain their market position.
Who Are CNGT's Key Customers?
- Retail consumers seeking health and wellness products.
- Wholesale distributors and retailers.
- Veterinary and agricultural customers.
- Online shoppers.
Company Profile
Cannagistics, Inc. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Hauppauge, US. The company is led by CEO James W. Zimbler. CNGT has traded publicly since 2006.
How Cannagistics, Inc. Is Valued
Relative to its peer group, CNGT's quantitative score of 44/100 is below the peer average of 63/100.
Key Financial Metrics
Return on equity for Cannagistics, Inc. stands at 336.6%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.01 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Cannagistics, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile.
CNGT Financials
Bull Case vs Bear Case
Bull Case
- Insider buying activity has increased recently, suggesting confidence from management in the company's future.
- Social sentiment has turned positive, with community discussions highlighting the potential for growth in the cannabis sector.
- Recent partnerships in the cannabis industry have strengthened Cannagistics' market position, attracting investor interest.
- Increased demand for cannabis products has been noted, indicating a favorable environment for companies like Cannagistics.
Bear Case
- Concerns over regulatory challenges in the cannabis industry have surfaced, making investors cautious about long-term viability.
- Community sentiment shows skepticism regarding Cannagistics' ability to scale operations effectively in a competitive market.
- Recent negative news about supply chain issues in the cannabis sector has raised doubts about Cannagistics' operational efficiency.
- Bearish views are prevalent, with some investors worried about potential market saturation affecting future growth prospects.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
CNGT Latest News
No recent news available for CNGT.
CNGT Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CNGT.
Price Targets
Wall Street price target analysis for CNGT.
CNGT MoonshotScore
What does this score mean?
The MoonshotScore rates CNGT 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Classification
Industry Shell CompaniesLeadership: James W. Zimbler
Managing
James W. Zimbler serves as the managing executive of Cannagistics, Inc. Information regarding Mr. Zimbler's detailed career history, educational background, and previous roles is not available in the provided data. His leadership is central to the company's strategic direction and operational execution. As managing executive, he oversees all aspects of the company's business, from product development and marketing to sales and distribution.
Track Record: Due to limited information, James W. Zimbler's specific achievements and strategic decisions at Cannagistics, Inc. cannot be fully assessed. The company's performance and milestones under his leadership require further evaluation based on available financial and operational data. His tenure is marked by the company's focus on developing and marketing a diverse range of health and wellness products.
CNGT OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Cannagistics, Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as exchange-listed companies. Investing in OTC Other stocks carries significant risks due to the potential for limited information and higher volatility. These stocks are typically more speculative and require a higher degree of due diligence.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Potential for low trading volume and liquidity.
- Higher price volatility compared to exchange-listed stocks.
- Increased risk of fraud or manipulation.
- Limited regulatory oversight and investor protection.
- Verify the company's financial statements and SEC filings (if available).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's revenue generation and profitability.
- Review the company's legal and regulatory compliance.
- Monitor trading volume and price volatility.
- Consult with a qualified financial advisor.
- Company's incorporation date (2004) suggests some operating history.
- Presence of a physical headquarters in Hauppauge, New York.
- Development and marketing of a range of health and wellness products.
- Active website and online presence (if available).
- Independent third-party verification of product claims (if available).
Common Questions About CNGT (Financial Services)
What does the AI Score mean for CNGT?
CNGT holds an AI Score of 44/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Cannagistics, Inc. operates as a developer, marketer, and seller of OTC, pharmaceutical, nutraceutical, cosmetic, and health and wellness products. The company offers a diverse portfolio …
What does Cannagistics, Inc. do?
Cannagistics, Inc. operates as a developer, marketer, and seller of a diverse range of over-the-counter (OTC), pharmaceutical, nutraceutical, cosmetic, and health and wellness products. Its portfolio includes items like Canagel, Silverpro, KidzStrips, and ImmuniZin, targeting areas such as pain relief, anti-aging, hygiene, energy, and immune support. The company distributes these products through wholesale, retail, and e-commerce channels, aiming to cater to a broad consumer base seeking health and wellness solutions.
What do analysts say about CNGT stock?
As of March 16, 2026, formal analyst coverage of Cannagistics, Inc. (CNGT) is unavailable due to its OTC listing and limited market capitalization. Key valuation metrics such as price targets and earnings estimates are not established. Investors should conduct independent due diligence, focusing on the company's financial disclosures, product performance, and competitive positioning. The stock's high beta of 3.28 suggests significant volatility, requiring careful risk management.
What are the main risks for CNGT?
Cannagistics, Inc. faces several key risks, including limited financial resources, intense competition from larger companies, and evolving consumer preferences. As an OTC-listed company, it is subject to less regulatory oversight and greater price volatility. The company's reliance on a small number of employees poses an operational risk. Investors should carefully assess these factors and conduct thorough due diligence before investing in CNGT.
How does Cannagistics, Inc. generate revenue?
Cannagistics, Inc. generates revenue primarily through the sale of its OTC, pharmaceutical, nutraceutical, cosmetic, and health and wellness products. Revenue streams are derived from wholesale distribution to retailers, direct sales to consumers through e-commerce platforms, and sales to veterinary and agricultural customers. The company's ability to generate consistent revenue depends on its product innovation, marketing effectiveness, and distribution network.
What is Cannagistics, Inc.'s strategy for growth in the financial services sector?
Cannagistics, Inc.'s growth strategy within the financial services sector, specifically as a shell company, involves leveraging its diverse product portfolio to generate revenue and attract potential acquisition targets or strategic partners. The company aims to expand its market reach through e-commerce and retail partnerships, while also investing in product development to address emerging consumer needs. Success hinges on effective execution, financial management, and compliance with regulatory requirements.
What are the key factors to evaluate for CNGT?
Cannagistics, Inc. (CNGT) holds an AI score of 44/100 (low). presents a high-risk, high-reward investment profile given its OTC listing and limited financial information. Not financial advice.
How frequently does CNGT data refresh on this page?
CNGT's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven CNGT's recent stock price performance?
Cannagistics, Inc. (CNGT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio across multiple health and wellness categories. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial information available for Cannagistics, Inc.
- OTC stocks are inherently more risky than exchange-listed stocks.
- AI analysis pending for CNGT.